Related Experiment Videos
Stereotactic resection and its limitations in glial neoplasms
1Department of Neurosurgery, Mayo Clinic, Rochester, Minn.
Stereotactic and Functional Neurosurgery
|January 1, 1992
Summary
Volumetric stereotactic techniques enable precise removal of intra-axial neoplasms. Differentiating tumor tissue from infiltrating cells in low-grade gliomas remains challenging, requiring stereotactic biopsy for accurate diagnosis.
Area of Science:
- Neurosurgery
- Oncology
- Radiology
Background:
- Intra-axial neoplasms can be precisely resected using imaging-based volumetric stereotactic techniques.
- Glial neoplasms comprise tumor tissue and infiltrating isolated tumor cells.
- Distinguishing tumor tissue from infiltrated parenchyma is crucial for effective treatment.
Purpose of the Study:
- To evaluate the efficacy of imaging-based volumetric stereotactic techniques for intra-axial neoplasm removal.
- To address the challenges in differentiating tumor components in low-grade gliomas.
- To define the appropriate application of stereotactic resection in eloquent brain areas.
Main Methods:
- Utilizing computed tomography (CT) and magnetic resonance imaging (MRI) for volumetric definition of neoplasms.
- Applying stereotactic techniques for selective tumor tissue resection.
- Employing stereotactic biopsy to differentiate tumor tissue from infiltrated parenchyma in hypodense regions.
Main Results:
- Volumetric stereotactic techniques allow accurate removal of CT/MRI-defined intra-axial neoplasms.
- Contrast enhancement accurately defines tumor tissue in high-grade gliomas and pilocytic astrocytomas.
- Low-grade nonpilocytic gliomas present imaging challenges, requiring stereotactic biopsy for differentiation.
Conclusions:
- Stereotactic resection is effective for the tumor tissue component of glial tumors, particularly in eloquent brain areas.
- Stereotactic biopsy is essential for accurate diagnosis of low-grade gliomas.
- Careful patient selection and diagnostic methods are vital for optimizing outcomes in glial tumor treatment.